Posts by: Iqra Mumal

News

Non-motor symptoms associated with the eventual development of Parkinson’s disease are prevalent in Gaucher disease type 1 patients — people who already are at a higher risk for the ... Read more

June 3, 2019

MicroRNA Inactivation Fails to Reduce Inflammation, Increase Survival in Zebrafish Models of Gaucher

News

Despite its well-known role in inflammation, the microRNA molecule known as miR-155 does not seem to be a promising target for the treatment of Gaucher disease, as its inactivation ... Read more

September 11, 2018

Sanofi’s Cerezyme Should Be Administered Under Current Guidelines with Potential for Change, Study Says

News

Newly discovered data on the activity of glucocerebrosidase after treatment with Sanofi Genzyme’s Cerezyme (imiglucerase) — an enzyme replacement therapy for Gaucher disease — supports current guidelines for its administration every ... Read more

July 10, 2018

Excess Sphingolipids in Gaucher Disease Plays Important Role in Bone Disease, Study Finds

News

An excess of sphingolipids — a hallmark of Gaucher disease — contributes to an imbalance in bone formation and degradation, leading to the development of bone disease, according to ... Read more

April 19, 2018

Gaucher Disease a Rare Cause of Liver, Spleen Enlargement, Case Report Finds

News

Hepatosplenomegaly — enlargement of the liver and spleen — can develop as a result of Gaucher disease in adults, according to a case report. The case report, “Gaucher disease ... Read more

April 12, 2018April 12, 2018

Simultaneous Enzyme Screening Detects Gaucher and Two Other Diseases, Study Reports

News

Looking for enzymes associated with Gaucher disease and two other disorders in the same dried blood sample is a good way to detect the disorders, a German and Austrian study ... Read more

March 8, 2018March 8, 2018

Gaucher Outcome Survey Helps Track Global Treatment Strategies

News

Medical professionals in several countries use a range of approaches to treat Gaucher disease (GD), and data from these strategies can help determine the impact of different treatment patterns ... Read more

March 6, 2018March 6, 2018

Pregnant Gaucher Disease Patients Can Continue Enzyme Replacement Therapy, Study Finds

News

Women receiving enzyme replacement therapy for Gaucher disease can continue taking it while pregnant with little risk of a miscarriage or a problem delivering their baby, a study suggests. ... Read more

November 16, 2017November 16, 2017

Baylor Study Links Mutations in Lysosomal Genes to Parkinson’s Disease

News

A new study by researchers at Houston’s Baylor College of Medicine has linked a group of genes associated with lysosomal storage disorders, such as Gaucher disease, to the onset ... Read more

October 24, 2017

Recently Identified Biomarker Could Be Valid Diagnostic Tool for Gaucher Disease, Mouse Study Suggests

News

Glucosylsphingosine (lyso-Gb1), a recently identified biomarker for Gaucher disease (GD), was shown to contribute to the development or peripheral symptoms in a mouse study, potentially validating its use as ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Non-motor Symptoms Preceding Parkinson’s Onset Prevalent in Gaucher Type 1, Study Finds

MicroRNA Inactivation Fails to Reduce Inflammation, Increase Survival in Zebrafish Models of Gaucher

Sanofi’s Cerezyme Should Be Administered Under Current Guidelines with Potential for Change, Study Says

Excess Sphingolipids in Gaucher Disease Plays Important Role in Bone Disease, Study Finds

Gaucher Disease a Rare Cause of Liver, Spleen Enlargement, Case Report Finds

Simultaneous Enzyme Screening Detects Gaucher and Two Other Diseases, Study Reports

Gaucher Outcome Survey Helps Track Global Treatment Strategies

Pregnant Gaucher Disease Patients Can Continue Enzyme Replacement Therapy, Study Finds

Baylor Study Links Mutations in Lysosomal Genes to Parkinson’s Disease

Recently Identified Biomarker Could Be Valid Diagnostic Tool for Gaucher Disease, Mouse Study Suggests

Pin It on Pinterest